Merge Healthcare Incorporated (NASDAQ: MRGE), a leading health IT solutions provider, today announced that Chief Executive Officer Jeff Surges will deliver a presentation at the UBS Annual Global Healthcare Services Conference on Monday, February 7, 2011. Mr. Surges will review the corporate vision and strategy beginning at 4:30 pm Eastern Time at the Grand Hyatt New York at Park Avenue at Grand Central in New York. Presentation materials will be available at: http://www.merge.com/investor/index.aspx.
As one of the world’s premier advisory and securities businesses, UBS Investment Bank provides clients with expert advice, innovative solutions, outstanding execution and comprehensive access to the world’s capital markets. This is the 21st annual healthcare conference for UBS, and includes presentations from over 100 of the leading healthcare services firms from around the world.
“Merge is honored to participate in this distinguished investor conference,” notes Mr. Surges. “We believe the company has an excellent value proposition for investors, and this is a wonderful forum to share our story.”
Merge Healthcare Incorporated develops and integrates information technology to create a better electronic healthcare experience. Merge products, ranging from standards-based development toolkits to sophisticated clinical applications, have been used by healthcare providers, vendors and researchers worldwide for over 20 years. Additional information can be found at www.merge.com.
Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.